The reason that fungi are such prolific elicitors of potent, and often specific, inhibitors of key enzymes and cellular receptors is not known. For the biologist, the most exciting thing about the discovery of a new fungal metabolite is the mystery that accompanies each new metabolite. What benefit does this chemical provide to the fungus? Does this metabolite have biological activity and, if so, what biomolecules does it target? Can it be useful to mankind or is it a toxin that could be harmful to our crops, farm animals, or ourselves? It is possible to roughly estimate the number of fungal metabolites, including those with toxic properties known as mycotoxins. In 1971 Turner cataloged approximately 1200 secondary fungal metabolites produced by approximately 500 species of fungi. In 1983 Turner and Alderidge cataloged 2000 more metabolites produced by approximately 1100 species. Thus, there were approximately two unique secondary metabolites/fungal species. In 1991, Hawksworth estimated that there were 69, 000 known fungal species and that these represented about 5% of the total known species in the world, which Hawksworth estimated at 1, 500, 000. Conservative estimates are on the order of 100, 000 species. Based on the work of Hawksworth and the assumption of two unique secondary metabolites/fungal species, there may be as many as 3, 000, 000 unique secondary fungal metabolites. The conservative estimate would be 200, 000. Between 1971 and 1983 the total number of known secondary fungal metabolites increased from 1, 200 to 3200. Assuming that the rate of discovery (accessible in the published literature) remained at a similar rate then approximately 12, 000 secondary fungal metabolites would be described by the end of 1998 (Fig. 1), less than 0.5% of the 3, 000, 000 or 6% of the 200, 000 unique compounds as estimated above. Clearly, the number of undiscovered secondary metabolites is quite large. Cole and Cox listed approximately 300 secondary fungal metabolites as mycotoxins, about 10% of the secondary fungal metabolites described by Turner and Turner and Alderidge. Thus, one can reason that there are potentially between 20, 000 and 300, 000 unique mycotoxins. The diversity of toxic mechanisms will be equally as great. Given the potentially large number of mycotoxins and the diversity of their mechanisms of action, the potential for extremely complex toxin interactions is also high. Given the past successes and hopes for the discovery of useful products, the immense chemical and mechanistic diversity of fungal metabolites is certainly good news. However, the same fungi that have served so well as chemical factories for producing useful drugs and research tools are also frequent contaminants of the food we eat and the air we breath and, thus, are potential agents of disease. In this sense, fungal metabolites are like a tripled edged sword, capable of cutting in three directions; as research tools for the biochemist, poisons to plants and animals, and therapeutic agents for the treatment of diseases. In this review, recently discovered fungal metabolites that inhibit de novo sphingolipid biosynthesis will be used as an example of this concept.
View full abstract